Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
2.940
-0.170 (-5.47%)
At close: Oct 9, 2026, 4:00 PM EDT
2.980
+0.040 (1.36%)
After-hours: Oct 9, 2026, 7:42 PM EDT
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year. That makes Quantum BioPharma the 38,817th largest employer in the world and 5,647th in the United States.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,479,927
Market Cap
23.78M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2022 | 17 | 7 | 70.00% | 17 | 0 |
| Dec 31, 2021 | 10 | 1 | 11.11% | 10 | 0 |
| Dec 31, 2020 | 9 | -9 | -50.00% | 9 | 0 |
| Dec 31, 2019 | 18 | -1 | -5.26% | 17 | 1 |
| Sep 30, 2019 | 23 | 4 | 21.05% | 23 | 0 |
| Jun 30, 2019 | 19 | - | - | 19 | 0 |
| Dec 31, 2018 | 19 | - | - | 19 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Evaxion | 46 |
| BeyondSpring | 44 |
| Kyntra Bio | 34 |
| ABVC BioPharma | 19 |
| Atossa Therapeutics | 16 |
| Cocrystal Pharma | 10 |
QNTM News
- 4 days ago - Quantum BioPharma signs contract with Thermo Fisher for sclerosis trial - TheFly
- 4 days ago - Quantum BioPharma Signs Contract with Thermo Fisher Scientific's Clinical Research Business to Implement Phase 2 Lucid-MS Trial in Multiple Sclerosis - GlobeNewsWire
- 10 days ago - IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. - GlobeNewsWire
- 16 days ago - Quantum BioPharma licensee Unbuzzed Wellness appoints Zapolin as CEO - TheFly
- 16 days ago - Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO - GlobeNewsWire
- 23 days ago - Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target - GlobeNewsWire
- 25 days ago - Quantum BioPharma to Attend the ArcStone-Kingswood Growth Summit 2026 in Toronto - Newsfile Corp
- 26 days ago - NetworkNewsAudio Announces Audio Press Release (APR) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment' in MS Research - GlobeNewsWire